Clinical implications of angiogenic factors in patients with acute or chronic leukemia: Hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia

REFERENCES

• Diaz-Flores L, Gutierrez R, Varela H. Angiogenesis: an update. Histol Histopathol 1994;9:807–843.
   PubMed Web of Science ®Google Scholar
• Folkman J. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757–1763.
   PubMed Web of Science ®Google Scholar
• Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931–10934.
   PubMed Web of Science ®Google Scholar
• Folkman J. Tumor angiogenesis; therapeutic implications. N Engl J Med 1971;285:1182–1186.
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27–31.
   PubMed Web of Science ®Google Scholar
• Ellis LM, Fidler IJ. Angiogenesis and metastasis. Eur J Cancer 1996;32A:2451–2460.
   PubMed Web of Science ®Google Scholar
• Salvin P, Teerenhovi L, Joensuu H. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood 1997;90:3167.
   Google Scholar
• Toi M, Hoshina S, Takayanagi T, Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 1994;85:1045.
   PubMedGoogle Scholar
• O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 1995;55:510.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995;55:3964.
   Google Scholar
• Aguayo A, Kantarjian H, Manshouri T et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000;96:2240–2245.
   PubMed Web of Science ®Google Scholar
• Aguayo A, O'Brien S, Keating M et al. Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia. Blood 2000;96:768–770.
   Google Scholar
• Aguayo A, Estey E, Kantarjian H et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood 1999;94:3717–3721.
   PubMed Web of Science ®Google Scholar
• Gruber G, Schwarzmeier JD, Shehata M, Hilgarth M, Berger R. Basic fibroblast growth factor is expressed by CD19/ CD1 1c-positive cells in hairy cell leukemia. Blood 1999;94: 1077–1185.
   Google Scholar
• Verstovsek S, Kantarjian H, Estey E et al. Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome. Leukemia 2001;15:1165–1170.
   PubMed Web of Science ®Google Scholar
• Janowska-Wieczorek A, Majka M, Marquez-Curtis L, Wertheim JA, Turner AR, Ratajczak MZ. Bcr-abl-positive cells secrete angiogenic factors including matrix metallopro-teinases and stimulate angiogenesis in vivo in Matrigel implants. Leukemia 2002;16:1160–1166.
   Google Scholar
• Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997;150:814–821.
   Google Scholar
• Pruneri G, Bertolini F, Soligo D et al. Angiogenesis in myelodysplastic syndromes. Br J Cancer 1999;81:1398–1401.
   PubMed Web of Science ®Google Scholar
• Lundberg LG, Lerner R, Sundelin P, Rogers R, Folkman J, Palmblad J. Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. Am J Pathol 2000;157:15–19.
   PubMed Web of Science ®Google Scholar
• Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000;95:309–313.
   Google Scholar
• Bussolino F, Di Renzo MF, Ziche Metal. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothe-lial cell motility and growth. J Cell Biol 1992;119:629–641.
   PubMed Web of Science ®Google Scholar
• Glenjen N, Anders K, Bruserud Q. Serum levels of angiogenin, basic fibroblast growth factor and endostatin in patient receiving intensive chemotherapy for acute myelogen-ous leukemia. Int J Cancer 2002;101:86–94.
   Google Scholar
• Lin U, Lin DT, Chang CJ, Lee CY, Tang JL, Tien HF. Marrow matrix metalloproteinases (MMPs) and tissue in-hibitors of MMP in acute leukaemia: potential role of MMP-9 as a surrogate marker to monitor leukaemic status in patients with acute myelogenous leukaemia. Br J Haematol 2002;117:835–841.
   PubMed Web of Science ®Google Scholar
• Padro T, Ruiz S, Bieker R et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000;95:2637–2644.
   PubMed Web of Science ®Google Scholar
• Vacca A, Ribatti D, Presta M et al. Bone marrow neovascu-larization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 1999;93:3064–3070.
   PubMed Web of Science ®Google Scholar
• Chen H, Treweeke AT, West DC et al. In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemic cells. Blood 2000;96:3181–3187.
   PubMed Web of Science ®Google Scholar
• Ratajczak MZ, Ratajczak J, Machalinski B et al. Role of vascular endothelial growth factor (VEGF), placenta derived growth factor (PIGF)/Flt-1 and Flk-1/KDR receptor axes in human adult and fetal hematopoiesis. Br J Haematol 1998;103:969–979.
   PubMed Web of Science ®Google Scholar
• Fiedler W, Graeven U, Ergun S et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 1997;89:1870–1875.
   PubMed Web of Science ®Google Scholar
• Olson KA, Verselis SJ, Fen JW. Angiogenin is regulated in vivo as an acute phase protein. Biochem Biophys Res Commun 1998;242:480–483.
   Google Scholar
• Ugurel S, Rappl G, Tilgen W, Reinhold U. Increased serum concentration of angiogenic factors in malignant melanoma patients correlate with tumor progression and survival. J Chin Oncol 2001;19:577–583.
   PubMed Web of Science ®Google Scholar
• Jiang W, Hiscox S, Matsumoto K, Nakamura T. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 1999;29:209–248.
   PubMed Web of Science ®Google Scholar
• Stevenson WG. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Chin Invest 1999;103:1237–1241.
   PubMed Web of Science ®Google Scholar
• Hjorth-Hansen H, Seidel C, Lamvik J, Borset M, Sundan A, Waage A. Elevated serum concentrations of hepatocyte growth factor in acute myelocytic leukaemia. Eur J Haematol 1999;62:129–134.
   Google Scholar
• Seidel C, Borset M, Turesson I, Abildgaard N, Sundan A, Waage A. Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group. Blood 1998;91:806–812.
   Google Scholar
• Borset M, Hjorth-Hansen H, Waage A, Sundan A. Hepato-cyte growth factor and its receptor c-met in multiple myeloma. Blood 1996;88:3998–4004.
   PubMed Web of Science ®Google Scholar
• Weimer IS, Voermans C, Boourhis JH et al. Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells. Leukemia 1998;12:1195–1203.
   PubMed Web of Science ®Google Scholar
• Beilmann M, Odenthal M, Jung W, Vande Woude GF, Dienes HP, Schirmacher P. Neo-expression of the c-met/ hepatocyte growth factor-scatter factor receptor gene in activated monocytes. Blood 1997;90:4450–4458.
   Google Scholar
• Banks RE, Forbes MA, Kinsey SE et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelet: significance for VEGF measurement and cancer biology. Br J Cancer 1998;77:956–964.
   PubMed Web of Science ®Google Scholar
• Molica S, Vitelli G, Levato D et al. Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of pa-tients with early B-cell chronic lymphocy-tic leukaemia. Eur J Haematol 2003;70:373–378.
   PubMed Web of Science ®Google Scholar